GLP-1 medications alter weight loss environment
GLP-1 medications alter weight loss environment by curbing hunger and reducing food intake effectively.
Pfizer submits vitiligo data for oral drug approval
Pfizer submits oral drug Litfulo data for nonsegmental vitiligo approval, a condition affecting about 70 million people worldwide.
Instacart and Unite Us partner on food benefits
Instacart and Unite Us partner on food benefits to simplify rollout of food-as-medicine initiatives for providers nationwide with grocery benefits.
FDA clears DreaMed’s CGM-based insulin dosing tool
FDA clears DreaMed’s MODI system, the first CGM-based tool for automated insulin dosing in Type 2 diabetes patients using multiple…
Doctors Remain Liable for AI Mistakes in Healthcare
AI liability in healthcare raises concerns as doctors may be held responsible for mistakes made by decision-support tools, prompting tighter…
ADARx Raises $535M in IPO for RNA-Targeted Therapies
ADARx raises $535M in IPO for RNA-targeted therapies, advancing siRNA-based treatments to degrade disease-causing proteins.
Patients Use AI Assistants to Record Doctor Visits
Patients use AI assistants to record doctor visits and reconstruct conversations for better follow-up care.
Startup raises $22M to expand at-home HPV screening
Teal Health raises $22M to expand its FDA-authorized at-home HPV screening device, offering self-collection and telehealth follow-up for cervical cancer…
IL-17 Inhibitors Show Low IBD Risk in HS Patients
IL-17 inhibitors show low IBD risk in HS patients, according to a recent review in JAMA Dermatology.
Oncologists Adopt AI Potential, But Few Use Predictive Models
Oncologists recognize AI's potential to enhance cancer care, yet only 19% utilize predictive models, revealing a significant implementation gap.